Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Pharmacogenomics. 2009 Aug;10(8):1243–1255. doi: 10.2217/pgs.09.71

Table 2.

Mean therapeutic and algorithm-predicted warfarin doses in the index patient.

Warfarin dose mg/week Ref.
Mean therapeutic dose 14.4
Algorithm-predicted dose
Sconce et al. (2005) 47.6 [41]
Wadelius et al. (2005) 49.7 [21]
Herman et al. (2006) 42.5 [51]
Takahashi et al. (2006) 50.3 [5]
Tham et al. (2006) 32.9 [52]
Anderson et al. (2007) 45.8 [53]
Miao et al. (2007) 49.1 [54]
Zhu et al. (2007) 52.2 [40]
Gage et al. (2008) 34.6 [16]
Schelleman et al. (2008) (C) 41.9 [17]
Schelleman et al. (2008) (AA) 28.4 [17]
Schelleman et al. (2008) (C + AA) 41.5 [17]
Wu et al. (2008) 24.9 [20]
Klein et al. (2009) 35.4 [6]
Wadelius et al. (2009) 50.1 [22]

Based on the following genotypes: CYP2C9: *1/*1; VKORC1 (Accession Number AY587020) g.-4931T>C (381T>C): T/C, g.-1639G>A (3673G>A): G/G, g.1173C>T (6484C>T): C/C, g.2255C>T (7566C>T): C/T, g.3730G>A (9041G>A): G/G; F7 g.-401G>T: G/G; APOE: ε2/ε3.

AA: African–American; C: Caucasian.